Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

10726

1

Wheels Up Experience Inc. Wheels Up Experience Inc. Reports 39% Revenue Decline, Improved Profitability in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

10727

1

INTELLIGENT BIO SOLUTIONS INC. Intelligent Bio Solutions Reports Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10728

1

Playtika Holding Corp. Playtika Holding Corp. Reports Mixed Q3 Results, Revenue Decline Offset by Operational Improvements and Strategic Growth

Via official filing (AI summary) | 6 months ago | 0 comments

10729

1

Nuveen Churchill Direct Lending Corp. Nuveen Churchill Direct Lending Corp. Reports Significant Financial Growth in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

10730

1

Amylyx Pharmaceuticals, Inc. Amylyx Pharmaceuticals Reports Significant Financial Challenges, Decline in Product Revenue, and Net Loss in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

10731

1

Third Harmonic Bio, Inc. Third Harmonic Bio Reports Financial Results, Advances Lead Product Candidate THB335

Via official filing (AI summary) | 6 months ago | 0 comments

10732

1

Rapid7, Inc. Rapid7 Reports 8% Revenue Growth, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10733

1

Oblong, Inc. Oblong, Inc. Reports Significant Financial Challenges in Q3 2024, Sees Revenue Decline and Net Loss

Via official filing (AI summary) | 6 months ago | 0 comments

10734

1

Tourmaline Bio, Inc. Tourmaline Bio Reports Significant Financial Developments, Raises $172.5 Million in Public Offering

Via official filing (AI summary) | 6 months ago | 0 comments

10735

1

Aptevo Therapeutics Inc. Aptevo Therapeutics Reports Significant Financial Challenges, Net Loss, and Cash Decline in Latest 10-Q Filing

Via official filing (AI summary) | 6 months ago | 0 comments

10736

1

PepGen Inc. PepGen Inc. Reports Financial Update, Advances Clinical Pipeline Despite Ongoing Losses

Via official filing (AI summary) | 6 months ago | 0 comments

10737

1

International Seaways, Inc. International Seaways Reports Decline in Revenues and Profitability for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10738

1

Acadian Asset Management Inc. BrightSphere Investment Group Reports Mixed Q3 Results, Revenue Growth, and Strategic Developments

Via official filing (AI summary) | 6 months ago | 0 comments

10739

1

Priority Technology Holdings, Inc. Priority Technology Holdings Reports 20.1% Revenue Growth, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10740

1

STERIS plc Steris Reports 7.3% Revenue Growth, Net Income Increase in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10741

1

PMV Pharmaceuticals, Inc. PMV Pharmaceuticals Reports Q3 Financial Results, Net Loss Improves Despite Increased R&D Expenses

Via official filing (AI summary) | 6 months ago | 0 comments

10742

1

iHeartMedia, Inc. iHeartMedia Reports Mixed Q3 2024 Results with Revenue Growth and Net Loss

Via official filing (AI summary) | 6 months ago | 0 comments

10743

1

Sunrise Realty Trust, Inc. Sunrise Realty Trust Reports Significant Financial Growth Following Spin-Off from Advanced Flower Capital Inc.

Via official filing (AI summary) | 6 months ago | 0 comments

10744

1

HilleVax, Inc. HilleVax Reports Decrease in Cash and Cash Equivalents, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10745

1

MESA LABORATORIES INC /CO/ Mesa Laboratories Reports 8.8% Revenue Growth, Turnaround in Operating Income and Net Income for Q3 and H1 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10746

1

ACORN ENERGY, INC. Acorn Energy Reports 28% Revenue Growth, Turnaround in Operating Income and Net Income for Nine Months Ended September 30, 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10747

1

VERACYTE, INC. Veracyte Reports 29% Revenue Growth, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10748

1

Vanda Pharmaceuticals Inc. Vanda Pharmaceuticals Reports 23% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 6 months ago | 0 comments

10749

1

AMEDISYS INC Amedisys Reports Revenue Growth, Decline in Profitability in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments

10750

1

Ikena Oncology, Inc. Ikena Oncology Reports Significant Financial Changes, Decline in Cash and Cash Equivalents in Latest Quarter

Via official filing (AI summary) | 6 months ago | 0 comments